The dust from the 2022 Midterm Elections has settled and the 118th Congress has begun. Republicans were successfully able to flip control of the House and now have a 222-212 majority with one vacancy to be filled. Democratic...more
1/18/2023
/ Child Tax Credit ,
Climate Change ,
Communications Decency Act ,
Congressional Review Act ,
Consolidated Appropriations Act (CAA) ,
Department of Energy (DOE) ,
Environmental Protection Agency (EPA) ,
Food and Drug Administration (FDA) ,
General Elections ,
Healthcare ,
Inflation Reduction Act (IRA) ,
Infrastructure ,
Infrastructure Investment and Jobs Act (IIJA) ,
Medicare ,
Pharmacy Benefit Manager (PBM) ,
Popular ,
Rapanos v US ,
SALT ,
State Elections ,
Tax Cuts and Jobs Act ,
US Army Corps of Engineers ,
Waters of the United States
Votes in the 2022 Midterm Elections are still being tallied. It will likely take several more days, if not weeks, to be able to confirm who will hold the majority in the House and Senate.Please note that House, Senate, and...more
11/11/2022
/ American Rescue Plan Act of 2021 ,
Budgets ,
Election Results ,
Food and Drug Administration (FDA) ,
Funding ,
General Elections ,
Inflation Reduction Act (IRA) ,
Infrastructure Investment and Jobs Act (IIJA) ,
Lame Duck Session ,
Medicare ,
Mental Health ,
NDAA ,
Physician Fee Schedule ,
SECURE Act ,
State Elections ,
Tax Cuts and Jobs Act
The 2022 Midterm Elections are a little over one month away and the races are tightening up. Democrats have seen their fortunes improve with a string of legislative victories and improving poll numbers for President Joe...more
10/3/2022
/ Community Development ,
Department of Health and Human Services (HHS) ,
Department of Veterans Affairs ,
Federal Elections ,
FEMA ,
Food and Drug Administration (FDA) ,
Political Candidates ,
Political Parties ,
State Elections ,
U.S. House ,
Ukraine ,
User Fees
As September gets underway and Washington returns from a busy recess, important deadlines loom. August saw the introduction and passage of the Inflation Reduction Act, the Biden Administration’s announcement of student debt...more
With just a few short weeks left until August recess, there is no shortage of items on the congressional to-do list. The latest round of Supreme Court decisions has inspired new action within Congress to pass legislation...more
7/8/2022
/ BsUFA ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Department of Health and Human Services (HHS) ,
Department of Labor (DOL) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
GDUFA ,
HELP ,
Infrastructure ,
Medicaid ,
Medical Device User Fee Program (MDUFA IV) ,
PDUFA ,
Proposed Legislation ,
Public Health Emergency ,
SCOTUS ,
Surprise Medical Bills ,
U.S. Treasury ,
User Fees
Unexpected events last month re-energized two key policy debates. In early May, a leaked draft opinion by Justice Samuel Alito showed that the Supreme Court is poised to overturn Roe v. Wade in its decision of Dobbs v....more
6/1/2022
/ America Competes Act ,
BsUFA ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Climate Change ,
Department of Health and Human Services (HHS) ,
Infrastructure Investment and Jobs Act (IIJA) ,
Medicaid ,
Medical Device User Fee Program (MDUFA IV) ,
National Institute of Health (NIH) ,
PDUFA ,
Primary Elections ,
Public Health Emergency ,
Regulatory Agenda ,
Roe v Wade ,
SAMHSA ,
SCOTUS ,
Semiconductors
Congress recently returned from its two-week recess with an extensive to-do list. Between now and the August recess, the House will be in session for a total of 32 legislative days, and the Senate will be in for 54...more
5/3/2022
/ America Competes Act ,
BsUFA ,
Centers for Disease Control and Prevention (CDC) ,
Climate Change ,
Coronavirus/COVID-19 ,
Corporate Taxes ,
FDA Reauthorization Act ,
GDUFA ,
Immigration Reform ,
Medical Device User Fee Program (MDUFA IV) ,
Mental Health ,
PDUFA ,
Price Inflation ,
SAMHSA ,
Tax Code
While Congress has a two-week recess in April, there are many priority items on the agenda this month. Less than two weeks after signing the Fiscal Year (FY) 2022 spending package, President Biden released his budget for FY...more
4/4/2022
/ America Competes Act ,
BsUFA ,
Budgets ,
Centers for Disease Control and Prevention (CDC) ,
Department of Energy (DOE) ,
Energy Sector ,
Food and Drug Administration (FDA) ,
GDUFA ,
Government Shutdown ,
Investment Tax Credits ,
Medical Device User Fee Program (MDUFA IV) ,
Mental Health ,
National Institute of Health (NIH) ,
NATO ,
Nominations ,
Oil & Gas ,
PDUFA ,
Public Health Emergency ,
Russia ,
SAMHSA ,
Semiconductors ,
SFC ,
Ukraine
The first day of spring is right around the corner and so are deadlines for congressional appropriations requests. This month, lawmakers are racing against the clock to fund the government and President Biden looks to...more
3/1/2022
/ Asset Freeze ,
Biden Administration ,
Coronavirus/COVID-19 ,
Department of Energy (DOE) ,
Department of Health and Human Services (HHS) ,
Economic Sanctions ,
Environmental Protection Agency (EPA) ,
Federal Budget ,
Infrastructure ,
National Institute of Health (NIH) ,
Nominations ,
Russia ,
SCOTUS ,
SWIFT ,
Ukraine ,
USAID
Despite February being a short month, various proposals are still on the table. As Congress returns from recess this week, it faces a daunting to-do list. Government funding runs out by mid-February, Democrats are looking for...more
As Congress returns from its holiday recess, January is shaping up to be a busy month in Washington, and 2022 will prove to be just as eventful. See below on what awaits Congress, and the upcoming agenda the Foley Federal...more
A mind-boggling example of administrative overreach, i.e. HHS’s issuance of overreaching regulations (in 2013) and sub-regulatory Guidance (in 2016), which impose a $22 billion lifetime regulatory cost ($1.52 billion per year...more
The Trump Administration has prioritized the elimination of overreaching regulations: In FY 2017, the Trump Administration reduced lifetime net regulatory costs across all agencies by $8.1 billion ($570 million per year)....more
12/12/2018
/ Accounting ,
Administrative Procedure Act ,
Department of Health and Human Services (HHS) ,
Disclosure Requirements ,
Electronic Medical Records ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare Reform ,
HITECH Act ,
Regulatory Agenda ,
Trump Administration
After a long, hard-fought, and often bitter campaign, the parties battled to a partisan draw. As expected, Democrats took over the House of Representatives. Democrats also flipped a number of Governors’ mansions, but lost...more
11/20/2018
/ Election Results ,
General Assembly ,
Governors ,
Legislative Agendas ,
Local Elections ,
Political Candidates ,
Political Parties ,
Public Policy ,
Senate Committees ,
State and Local Government ,
State Elections
...Alexander: Senate Sends Opioids Legislation Called “Landmark” by Leader McConnell to President – On Wednesday, the U.S. Senate passed by a vote of 98-1, the SUPPORT for Patients and Communities Act, sponsored by Senator...more
10/11/2018
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Electronic Medical Records ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Opioid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Trump Administration
Here are some key health care policy headlines from the past week that you may have missed.
Congress -
Legislation and Committee Activity -
Bloomberg: Opioids Compromise Already in the Works in Congress – Congress is...more
9/27/2018
/ Acts of Congress ,
Centers for Medicare & Medicaid Services (CMS) ,
Continuing Resolution ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Gag Clauses ,
HELP ,
OMB ,
Opioid ,
Prescription Drugs ,
Proposed Rules ,
Regulatory Agenda ,
Telemedicine ,
Trump Administration
Congress is back in session after the August recess and, as expected, a flurry of activity took place. Here are some key health care policy headlines from the past week that you may have missed....more
9/13/2018
/ Acts of Congress ,
Affordable Care Act ,
Drug Pricing ,
HELP ,
HRSA ,
Opioid ,
Pharmacy Benefit Manager (PBM) ,
Primary Elections ,
Regulatory Agenda ,
Section 340B ,
Trump Administration
Foley’s Bipartisan Public Policy Team is pleased to share our Public Policy August Recess Health Care Newsletter in which we compiled the top health care policy news and legislation from this month. The House was not in...more
8/28/2018
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Employee Retirement Income Security Act (ERISA) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare ,
HELP ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Prescription Drugs
Foley & Lardner LLP’s Bipartisan Public Policy Team is pleased to share this week’s “Public Policy Health Care Newsletter” in which we compile the latest health care policy news and legislation. Please note that the next...more
7/30/2018
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
GAO ,
Health Insurance ,
Healthcare Reform ,
HELP ,
Legislative Agendas ,
Medicare ,
Medicare Part D ,
MIPS ,
National Institute of Health (NIH) ,
Opioid ,
Prescription Drugs ,
Section 340B ,
Trump Administration
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health Care policy news and legislation. *Please note that we...more
7/24/2018
/ Appropriations Bill ,
Biosimilars ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Federal Budget ,
Food and Drug Administration (FDA) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Legislative Committees ,
Medicaid ,
Medicare ,
Medicare Access and CHIP Reauthorization (MACRA) ,
Opioid ,
Secretary of HHS ,
Stark Law ,
Trump Administration
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health Care policy news and legislation. *Please note that we...more
7/16/2018
/ Affordable Care Act ,
Appropriations Bill ,
Association Health Plans ,
Centers for Medicare & Medicaid Services (CMS) ,
DEA ,
Department of Education ,
Department of Health and Human Services (HHS) ,
Department of Labor (DOL) ,
Electronic Health Record Incentives ,
Employee Retirement Income Security Act (ERISA) ,
Food and Drug Administration (FDA) ,
Funding Opportunities ,
GAO ,
Health Insurance ,
Health Savings Accounts ,
Healthcare Reform ,
HELP ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Medicare Advantage ,
Opioid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Legislation ,
Proposed Regulation ,
Section 340B ,
Telemedicine
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more
7/2/2018
/ Appropriations Bill ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Healthcare ,
Healthcare Fraud ,
HELP ,
Legislative Agendas ,
Medicaid ,
Medicare ,
New Legislation ,
Opioid ,
Pharmaceutical Industry ,
Proposed Legislation ,
Section 340B ,
Senate Finance Committee ,
Substance Abuse ,
Trump Administration ,
Veterans Administration
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more
6/26/2018
/ Affordable Care Act ,
Agency Consolidation ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Reform ,
HELP ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Opioid ,
Prescription Drugs ,
SAMHSA ,
Stark Law ,
State and Local Government ,
Trump Administration
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more
6/21/2018
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Healthcare ,
HELP ,
Hospitals ,
Medicaid ,
Medicare ,
National Institute of Health (NIH) ,
Opioid ,
Pharmaceutical Industry ,
Proposed Legislation ,
Secretary of HHS ,
Senate Finance Committee ,
Substance Abuse ,
Trump Administration
Foley’s Bipartisan Public Policy Team is pleased to share our “Public Policy Health Care Newsletter” in which we compile the latest health care policy news and legislation. *Please note that we publish this newsletter only...more
6/12/2018
/ Affordable Care Act ,
Appropriations Bill ,
Centers for Medicare & Medicaid Services (CMS) ,
Cybersecurity ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Food and Drug Administration (FDA) ,
GAO ,
HELP ,
Legislative Agendas ,
Legislative Committees ,
Medicare ,
Medicare Part D ,
National Institute of Health (NIH) ,
Opioid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Preventive Health Care ,
Substance Abuse ,
Trump Administration ,
Ways and Means Committee